Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.42 |
| ▸ | LMNA | P02545 | 4/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | AHR | P35869 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | DHODH | Q02127 | 3/20 | 0.38 |
| ▸ | AKT1 | P31749 | 1/20 | 0.37 |
| ▸ | AKT2 | P31751 | 1/20 | 0.37 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6724927 | 0.99 | L3MBTL1 (0.46) | L3MBTL1KDM4ELMNAALDH1A1GAA | |
| SCHEMBL12146775 | 0.99 | L3MBTL1 (0.46) | L3MBTL1KDM4ELMNAALDH1A1GAA | |
| SCHEMBL12207324 | 0.99 | L3MBTL1 (0.46) | L3MBTL1KDM4ELMNAALDH1A1GAA | |
| SCHEMBL12146765 | 0.97 | L3MBTL1 (0.49) | L3MBTL1KDM4ELMNAALDH1A1GAA | |
| SCHEMBL12146769 | 0.97 | L3MBTL1 (0.49) | L3MBTL1KDM4ELMNAALDH1A1GAA | |
| SCHEMBL12690621 | 0.94 | CA12 (0.42) | L3MBTL1KDM4ELMNAALDH1A1GAA | |
| SCHEMBL12146632 | 0.91 | L3MBTL1 (0.45) | L3MBTL1KDM4ELMNAALDH1A1GAA | |
| SCHEMBL12146605 | 0.90 | L3MBTL1 (0.46) | L3MBTL1KDM4ELMNAALDH1A1GAA | |
| SCHEMBL10315127 | 0.88 | ATR (0.47) | L3MBTL1KDM4ELMNAALDH1A1GAA | |
| SCHEMBL12207675 | 0.87 | L3MBTL1 (0.44) | L3MBTL1KDM4ELMNAALDH1A1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110284835-A1 | Quinoxaline Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using the Same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2011-11-24 | — | — | US | disclosed |
| US-20110284835-A1 | Quinoxaline Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using the Same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2011-11-24 | — | — | US | disclosed |
| US-7993761-B2 | Quinoxaline derivative, and light-emitting element, light-emitting device, and electronic device using the same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-08-09 | — | — | US | disclosed |
| US-7993761-B2 | Quinoxaline derivative, and light-emitting element, light-emitting device, and electronic device using the same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-08-09 | — | — | US | disclosed |
| US-20090140644-A1 | Quinoxaline Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using the Same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2009-06-04 | — | — | US | disclosed |
| US-20090140644-A1 | Quinoxaline Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using the Same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2009-06-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090140644-A1 | Quinoxaline Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using the Same | CRY1, CYP1A1, CRY2 | L3MBTL1 1076/4885KDM4E 1488/4885LMNA 2622/4885 |
| US-20110284835-A1 | Quinoxaline Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using the Same | CRY1, CYP1A1, NQO1 | L3MBTL1 1264/4885KDM4E 1780/4885LMNA 2781/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.